Accept no substitute

Although there are benefits to allogeneic transfusion, there are still concerns about disease transmission. Current preventive strategies are rigorous prephlebotomy donor screening and testing for antibodies, and researchers guarantee that the number of disease-marker tests will doubtless increase.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1997-12, Vol.350, p.SIII27-SIII27
Main Author: Widmann, Frances K
Format: Article
Language:English
Subjects:
Blood & organ donations
Disease
Disease transmission
Medical research
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although there are benefits to allogeneic transfusion, there are still concerns about disease transmission. Current preventive strategies are rigorous prephlebotomy donor screening and testing for antibodies, and researchers guarantee that the number of disease-marker tests will doubtless increase.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(97)90060-X